Ulrich Gerlach

415 citations
15 papers · 194 indexed · h-index 8
Topics
Amino Acid Enzymes and Metabolism (3 papers)Metabolism and Genetic Disorders (3 papers)Neuroendocrine Tumor Research Advances (2 papers)

In The Last Decade

Ulrich Gerlach

15 papers receiving 174 citations

Peers

Ulrich Gerlach
Comparison fields: 5 of 65
  • Epidemiology 57
  • Molecular Biology 54
  • Surgery 24
  • Endocrinology, Diabetes and Metabolism 23
  • Pharmacology 22
Replace Novikoff Ab with:
Novikoff Ab
Milena Stanković Serbia
Mutsuo Shigemoto Japan
Xingwu Teng United States
Shinitsu Hatakeyama Japan
H. Jensen United States
Yan‐Wen Shu China
Anna Walentinsson Sweden
J. Capeau France
M. N. Rudra United States
Ulrich Gerlach relative to Novikoff Ab Novikoff Ab's profile →
Citations per field
00.5×3.1×
Novikoff Ab · 1×
Citations per year

Countries citing papers authored by Ulrich Gerlach

Since Specialization
Citations

This map shows the geographic impact of Ulrich Gerlach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrich Gerlach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrich Gerlach more than expected).

Fields of papers citing papers by Ulrich Gerlach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrich Gerlach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrich Gerlach. The network helps show where Ulrich Gerlach may publish in the future.

Co-authorship network of co-authors of Ulrich Gerlach

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrich Gerlach. A scholar is included among the top collaborators of Ulrich Gerlach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrich Gerlach. Ulrich Gerlach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
#WorkIndexed citations
1 17
2 36
3 15
4 20
5 2
6
Die unspezifische Mesenchymreaktion : zur Pathogenese der reaktiven Mesenchymerkrankungen
16
7 7
8 5
9 8
10 3
11 25
12 7
13 30
14 2
15 1

About Ulrich Gerlach

Ulrich Gerlach is a scholar working on Biochemistry, Clinical Biochemistry and Genetics, having authored 15 papers that have together received 194 indexed citations. Recurring topics across this work include Amino Acid Enzymes and Metabolism (3 papers), Metabolism and Genetic Disorders (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Pharmacology (22 citations), Hepatology (20 citations) and Clinical Biochemistry (17 citations). Ulrich Gerlach has collaborated with scholars based in Germany, Switzerland and United States. Frequent co-authors include Hermann Wagner, Karin Hengst, Klaus‐Michael Müller, B. Voß, Gerhard J. Jungehülsing, W. H. Hauß, H. Themann, Albert Roessner, Michael Althaus and Jürgen Rauterberg. Their work appears in journals such as Clinica Chimica Acta, Atherosclerosis and Metabolism.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026